Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.

Lower drug costs for Medicare recipients

If enacted, this bill would change Medicare Part D formularies for plan years that begin on or after January 1, 2027. If you have Medicare Part D, your plan would have to put any covered generic whose wholesale acquisition cost (WAC) is lower than the brand on a more favorable tier with lower out-of-pocket costs. For each reference biological product, your plan would have to put at least two covered biosimilars whose WAC is lower than the reference into preferred positions. Plans would not be allowed to use prior authorization, step therapy, or other limits that make those required generics or biosimilars harder to get than the reference product.